Insider Trades
Common-stock transactions that officers, directors and 10% owners of healthcare companies report to the SEC on Form 4, from 2006 to today, newest first.
Insider filings are public records and are not a recommendation.
Results
25+ transactions, newest first
| Date | Insider | Relationship | Company | Transaction | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|
| MCGLYNN MARGARET G | Director | AMICUS THERAPEUTICS, INC. | OtherD · Sale or transfer back to the company | 94,631 | $14.50 | $1,372,149.50 | 0Direct | Form 4 filed 27 Apr 2026, on sec.gov (opens in a new tab)Filed 27 Apr 2026 | |
| RAAB MICHAEL | Director | AMICUS THERAPEUTICS, INC. | OtherD · Sale or transfer back to the company | 115,857 | $14.50 | $1,679,926.50 | 0Direct | Form 4 filed 27 Apr 2026, on sec.gov (opens in a new tab)Filed 27 Apr 2026 | |
| Campbell Bradley L | Director, President and CEO | AMICUS THERAPEUTICS, INC. | OtherD · Sale or transfer back to the company | 1,008,680 | $14.50 | $14,625,860 | 0Direct | Form 4 filed 27 Apr 2026, on sec.gov (opens in a new tab)Filed 27 Apr 2026 | |
| WHEELER CRAIG A | Director | AMICUS THERAPEUTICS, INC. | OtherD · Sale or transfer back to the company | 84,631 | $14.50 | $1,227,149.50 | 0Direct | Form 4 filed 27 Apr 2026, on sec.gov (opens in a new tab)Filed 27 Apr 2026 | |
| Clark David Michael | Chief People Officer | AMICUS THERAPEUTICS, INC. | OtherD · Sale or transfer back to the company | 221,811 | $14.50 | $3,216,259.50 | 0Direct | Form 4 filed 27 Apr 2026, on sec.gov (opens in a new tab)Filed 27 Apr 2026 | |
| ROBERTS EIRY | Director | AMICUS THERAPEUTICS, INC. | OtherD · Sale or transfer back to the company | 76,275 | $14.50 | $1,105,987.50 | 0Direct | Form 4 filed 27 Apr 2026, on sec.gov (opens in a new tab)Filed 27 Apr 2026 | |
| WHITMAN BURKE W | Director | AMICUS THERAPEUTICS, INC. | OtherD · Sale or transfer back to the company | 118,598 | $14.50 | $1,719,671 | 0Direct | Form 4 filed 27 Apr 2026, on sec.gov (opens in a new tab)Filed 27 Apr 2026 | |
| Harford Simon N.R. | Chief Financial Officer | AMICUS THERAPEUTICS, INC. | OtherD · Sale or transfer back to the company | 143,595 | $14.50 | $2,082,127.50 | 0Direct | Form 4 filed 27 Apr 2026, on sec.gov (opens in a new tab)Filed 27 Apr 2026 | |
| Rosenberg Ellen | Chief Legal Officer | AMICUS THERAPEUTICS, INC. | OtherD · Sale or transfer back to the company | 15,000 | $14.50 | $217,500 | 0Indirect | Form 4 filed 27 Apr 2026, on sec.gov (opens in a new tab)Filed 27 Apr 2026 | |
| Rosenberg Ellen | Chief Legal Officer | AMICUS THERAPEUTICS, INC. | OtherD · Sale or transfer back to the company | 463,898 | $14.50 | $6,726,521 | 0Direct, By Spouse | Form 4 filed 27 Apr 2026, on sec.gov (opens in a new tab)Filed 27 Apr 2026 | |
| Castelli Jeff | Chief Development Officer | AMICUS THERAPEUTICS, INC. | OtherD · Sale or transfer back to the company | 427,089 | $14.50 | $6,192,790.50 | 0Direct | Form 4 filed 27 Apr 2026, on sec.gov (opens in a new tab)Filed 27 Apr 2026 | |
| Bleil Lynn Dorsey | Director | AMICUS THERAPEUTICS, INC. | OtherD · Sale or transfer back to the company | 113,941 | $14.50 | $1,652,144.50 | 0Direct | Form 4 filed 27 Apr 2026, on sec.gov (opens in a new tab)Filed 27 Apr 2026 | |
| SBLENDORIO GLENN | Director | AMICUS THERAPEUTICS, INC. | OtherD · Sale or transfer back to the company | 142,564 | $14.50 | $2,067,178 | 0Direct | Form 4 filed 27 Apr 2026, on sec.gov (opens in a new tab)Filed 27 Apr 2026 | |
| Kelly Michael Aaron | Director | AMICUS THERAPEUTICS, INC. | OtherD · Sale or transfer back to the company | 72,468 | $14.50 | $1,050,786 | 0Direct | Form 4 filed 27 Apr 2026, on sec.gov (opens in a new tab)Filed 27 Apr 2026 | |
| Prout Samantha | Chief Accounting Officer | AMICUS THERAPEUTICS, INC. | OtherD · Sale or transfer back to the company | 125,951 | $14.50 | $1,826,289.50 | 0Direct | Form 4 filed 27 Apr 2026, on sec.gov (opens in a new tab)Filed 27 Apr 2026 | |
| Campbell Bradley L | Director, President and CEO | AMICUS THERAPEUTICS, INC. | SellS · Open-market or private sale | 22,500 | $14.35 | $322,875 | 998,680Direct | Form 4 filed 4 Mar 2026, on sec.gov (opens in a new tab)Filed 4 Mar 2026 | |
| Campbell Bradley L | Director, President and CEO | AMICUS THERAPEUTICS, INC. | SellS · Open-market or private sale | 75,000 | $14.31 | $1,073,250 | 1,021,180Direct | Form 4 filed 22 Jan 2026, on sec.gov (opens in a new tab)Filed 22 Jan 2026 | |
| Campbell Bradley L | Director, President and CEO | AMICUS THERAPEUTICS, INC. | OtherM · Option or derivative exercised or converted | 75,000 | $6.10 | $457,500 | 1,096,180Direct | Form 4 filed 22 Jan 2026, on sec.gov (opens in a new tab)Filed 22 Jan 2026 | |
| Rosenberg Ellen | Chief Legal Officer | AMICUS THERAPEUTICS, INC. | OtherF · Shares withheld to pay tax or exercise price | 29,683 | $14.27 | $423,576.41 | 464,601Direct | Form 4 filed 6 Jan 2026, on sec.gov (opens in a new tab)Filed 6 Jan 2026 | |
| Prout Samantha | Chief Accounting Officer | AMICUS THERAPEUTICS, INC. | OtherF · Shares withheld to pay tax or exercise price | 12,240 | $14.27 | $174,664.80 | 125,951Direct | Form 4 filed 6 Jan 2026, on sec.gov (opens in a new tab)Filed 6 Jan 2026 | |
| Clark David Michael | Chief People Officer | AMICUS THERAPEUTICS, INC. | OtherF · Shares withheld to pay tax or exercise price | 18,498 | $14.27 | $263,966.46 | 221,811Direct | Form 4 filed 6 Jan 2026, on sec.gov (opens in a new tab)Filed 6 Jan 2026 | |
| Castelli Jeff | Chief Development Officer | AMICUS THERAPEUTICS, INC. | OtherF · Shares withheld to pay tax or exercise price | 23,102 | $14.27 | $329,665.54 | 409,311Direct | Form 4 filed 6 Jan 2026, on sec.gov (opens in a new tab)Filed 6 Jan 2026 | |
| Rosenberg Ellen | Chief Legal Officer | AMICUS THERAPEUTICS, INC. | OtherF · Shares withheld to pay tax or exercise price | 13,426 | $14.27 | $191,589.02 | 494,284Direct | Form 4 filed 6 Jan 2026, on sec.gov (opens in a new tab)Filed 6 Jan 2026 | |
| Prout Samantha | Chief Accounting Officer | AMICUS THERAPEUTICS, INC. | OtherF · Shares withheld to pay tax or exercise price | 3,443 | $14.27 | $49,131.61 | 138,191Direct | Form 4 filed 6 Jan 2026, on sec.gov (opens in a new tab)Filed 6 Jan 2026 | |
| Clark David Michael | Chief People Officer | AMICUS THERAPEUTICS, INC. | OtherF · Shares withheld to pay tax or exercise price | 5,381 | $14.27 | $76,786.87 | 240,309Direct | Form 4 filed 6 Jan 2026, on sec.gov (opens in a new tab)Filed 6 Jan 2026 |
Source: SEC EDGAR Form 4 filings and the SEC Insider Transactions Data Sets (2006 onward). Each row links to its Form 4 filing. Values are shares times the reported price. Nothing here is investment advice.